Segmentation of patients with small cell lung cancer into responders and non-responders using the optimal cross-validation technique
Abstract Background The timing of treating cancer patients is an essential factor in the efficacy of treatment. So, patients who will not respond to current therapy should receive a different treatment as early as possible. Machine learning models can be built to classify responders and nonresponder...
| Published in: | BMC Medical Research Methodology |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-04-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12874-024-02185-7 |